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Abstract: Investigations into the safety of ultrasonography in preg-
nancy have focused on the potential harm of ultrasound itself. However,
no data have been published regarding the electromagnetic fields
that ultrasound devices might produce. This study is the first to
measure extremely low-frequency magnetic field (ELF-MF) exposure
of clinicians and pregnant women during prenatal ultrasound examin-
ations in the examination room from 2 different ultrasound devices
and compare them with ELF-MFs during patient consultation in the
consulting room.
The ELF-MF intensities that clinicians and pregnant women were
exposed to were measured every 10 seconds for 40 prenatal ultrasound
examinations using Philips iU22 or Accuvix V20 Prestige machines and
20 patient consultations in a consulting room using portable ELF-MF
measurement devices.
The mean ELF-MF exposure of both clinicians and pregnant women
was 0.18 0.06mG during prenatal ultrasound examination. During
patient consultation, the mean ELF-MF exposures of clinicians and
pregnant women were 0.10 0.01 and 0.11 0.01mG, respectively.
Mean ELF-MF exposures during prenatal ultrasound examination were
significantly higher than those during patient consultations (P< 0.001
by Mann–Whitney U test).
Our results provide basic reference data on the ELF-MF exposure of
both clinicians and pregnant women during prenatal ultrasound
monitoring from 2 different ultrasound devices and patient consultation,
all of which were below 2mG, the most stringent level considered safe
in many studies, thus relieving any anxiety of clinicians and pregnant
women regarding potential risks of ELF-MFs.Chung, MS, and n, MD, PhD,
and Hee Young Cho, MDINTRODUCTION
U ltrasound, widely accepted in clinical practice for more than4 decades, can improve pregnancy outcomes by significantly
reducing perinatal mortality.1–3 However, while ultrasound
examination is widely considered safe to the developing embryo
or fetus, the evidence is still limited. Since ultrasound is a form of
energy, it has the potential to produce biological effects that could
constitute a health risk.4 Therefore, all studies investigating the
safety of the examination have focused on the potential harm of
ultrasound itself. However, to the best of our knowledge, up to the
present there have been no studies focused on the electromagnetic
fields that ultrasound devices produce.
Between electric and magnetic fields (MFs), which com-
prise electromagnetic fields, most recent studies have focused
on the health effects of MFs, since they are less easily blocked.5
Along the MF spectrum, extremely low-frequency MFs (ELF-
MFs), which include the 50- and 60-Hz frequencies used in
power lines and electric appliances,6 range from 3 to 3000Hz.
ELF-MF is classified as possibly carcinogenic to humans
(Group 2B) by the International Agency for Research on
Cancer.7 Wertheimer and Leeper8 first reported increased
development of childhood cancer in association with proximity
of the home to electrical power lines.
Little attention has been given to the potential ELF-MF
risk of the many electrical devices critical to disease treatment
and diagnosis in hospitals. Many groups have reported potential
harmful effects of ELF-MFs including cardiovascular disease,
breast cancer, cognitive dysfunction, and dementia.9–14 More-
over, high ELF-MF exposure during pregnancy increased the
risk of childhood leukemia and early pregnancy loss due to its
effects on embryonic development.15,16 Therefore, the effect of
ELF-MFs produced by ultrasound devices should not be over-
looked. However, there have been no reports regarding the EFL-
MF levels that clinicians and pregnant women are exposed to
during prenatal ultrasound examinations. To our knowledge,
this study is the first to measure the ELF-MF exposure of
clinicians and pregnant women during prenatal ultrasound
examinations in the examination room from 2 different ultra-
sound devices and compare those exposure levels with ELF-MF
exposure during patient consultations in the consulting room.
METHODS
Subjects
ELF-MF exposure levels of clinicians and pregnant women
were measured from February to April 2015 during 40 prenatal
ultrasound examinations in the examination room and 20 patient
consultations in the consulting room at the Yonsei Universityul, Korea. Twenty prenatal ultrasound
ilips iU22 (Philips Healthcare Solutions,
d device, and 20 examinations used an
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Park et al Medicine  Volume 94, Number 29, July 2015Accuvix V20 Prestige (Samsung Medison Co Ltd, Seoul,
Korea) ultrasound device. All subjects were informed of the
purpose and procedure of the experiments and provided written
consent before joining the study. The Yonsei University Health
System Institutional Review Board approved the study protocol
(project no: 4-2015-0012).
Measurement of ELF-MFs
Tomeasure theELF-MFexposure levels of clinicians during
prenatal ultrasound examinations and patient consultation, an
EMDEX Lite (Enertech Consultants, Campbell, CA), a portable
device to periodically measure ELF-MF intensity, was fitted into
position over each clinician’s heart during each prenatal ultra-
sound examination and patient consultation (Figure 1A). To
measure ELF-MF exposure levels of the pregnant women during
prenatal ultrasound examinations, an EMDEX II (Enertech Con-
sultants), a portable device to periodically measure ELF-MF
intensity, was installed under the bed as close as possible to
the position of the maternal abdomen during prenatal ultrasound
examination (Figure 1B). To measure the ELF-MF exposure
levels of pregnant women during patient consultation, an
EMDEX II (Enertech Consultants) was installed at the back of
the chair where pregnant women typically sat during their visit
with clinicians, corresponding to the nearest position to the
maternal abdomen (Figure 1C). The EMDEX Lite can measure
ELF-MFs between 40 and 1000Hz and ranging from 0.1 to
700.0mG with a resolution of 0.1mG and accuracy of 2%.
The EMDEX II can measure ELF-MFs between 40 and 800Hz,
ranging from 0.1 to 3000.0mG with a resolution of 0.1mG and
accuracy of1%.The ELF-MF intensitywas sampled and stored
by the devices every 10 seconds from the start to completion of
each examination. The datawere then retrieved by connecting the
measuring device to a personal computer and analyzed by
EMCALC 2000 (Enertech Consultants) analysis and graphical
software.
Statistical Analyses
The mean and standard deviation of ELF-MF intensity
during each examination were calculated. The Mann–Whitney
FIGURE 1. (A) The EMDEX Lite was fitted on over each clinician’s
ultrasound examination. (C) Installation of the EMDEX II at the bU test was used to compare the mean ELF-MF exposures of
clinicians and pregnant women during patient consultation and
prenatal ultrasound examinations from 2 different ultrasound
2 | www.md-journal.comdevices (Philips iU22 and Accuvix V20 Prestige). SPSS soft-
ware version 20.0 (SPSS, Inc., Chicago, IL) was used for
statistical analyses. All reported P values were 2-tailed, and
P values <0.05 were considered statistically significant.
RESULTS
ELF-MF exposure levels during patient consultation in the
consulting roomandduring prenatal ultrasound examinationwith
either different ultrasound device, the Philips iU22, and the
Accuvix V20 Prestige are presented in Tables 1–3, respectively.
Table 4 shows the comparison of mean ELF-MF exposure of
clinicians and pregnant women during patient consultation and
prenatal ultrasound examination. In 40 total prenatal ultrasound
examinations, mean ELF-MF exposure was 0.18 0.06mG for
both clinicians and pregnant women. In 20 patient consultations,
the mean ELF-MF exposures of clinicians and pregnant women
were 0.10 0.01 and 0.11 0.01mG, respectively. The mean
ELF-MF exposures of both clinicians and pregnant women
during prenatal ultrasound examinationwere significantly higher
those during patient consultation. Furthermore, the mean ELF-
MF exposures from the Philips iU22 and Accuvix V20 Prestige
devices, analyzed separately, were both significantly higher
(P< 0.001 by Mann–Whitney U test) than ELF-MF exposure
during patient consultation (Table 5). Mean ELF-MF exposures
of clinicians and pregnant women from the Philips iU22 device
(0.24 0.03 and 0.24 0.02mG) were significantly higher than
those from the Accuvix V20 Prestige device (0.13 0.02 and
0.13 0.01mG) (P< 0.001 byMann–WhitneyU test) (Table 6).
DISCUSSION
In our study, the mean ELF-MF exposure of both clinicians
and pregnant women was 0.18 0.06mG (n¼ 40 each) during
prenatal ultrasound examination in the examination room.
During patient consultation in the consulting room, the mean
ELF-MF exposures of clinicians and pregnant women were
0.10 0.01 (n¼ 20) and 0.11 0.01mG (n¼ 20), respectively.
Although mean ELF-MF exposure was higher during prenatal
ultrasound examination than during patient consultation, all
ELF-MF measurements were below 2mG, which is considered
rt. (B) Installation of the EMDEX II under the bed during prenatal
of the chair during patient consultation.a safe limit in many epidemiological studies and guidelines
suggested by the Swedish Board for Technical Accreditation
for computer monitors.17–20 Moreover, the mean ELF-MF
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Exposure Levels of Clinicians and Pregnant Women
to Extremely Low-Frequency Magnetic Fields During Patient
Consultation in the Consulting Room
MF Exposure (mG)
Case
Duration of
Measurement
(seconds)
Number of
Measurements

Min Max Mean SD
C1 110 12 0.1 0.1 0.10 0.02
C2 50 6 0.1 0.1 0.10 0.03
C3 50 6 0.1 0.1 0.09 0.02
C4 170 18 0.1 0.1 0.12 0.02
C5 110 12 0.1 0.1 0.11 0.03
C6 110 12 0.1 0.1 0.10 0.03
C7 50 6 0.1 0.1 0.08 0.00
C8 110 12 0.1 0.1 0.09 0.02
C9 290 30 0.1 0.2 0.11 0.04
C10 410 42 0.1 0.2 0.11 0.04
C11 50 6 0.1 0.1 0.09 0.02
C12 230 24 0.1 0.1 0.10 0.03
C13 50 6 0.1 0.2 0.10 0.04
C14 110 12 0.1 0.1 0.12 0.02
C15 110 12 0.1 0.1 0.11 0.02
C16 230 24 0.1 0.1 0.12 0.03
C17 170 18 0.1 0.1 0.12 0.02
C18 50 6 0.1 0.1 0.10 0.03
C19 50 6 0.1 0.1 0.11 0.03
C20 110 12 0.1 0.1 0.11 0.03
P1 110 12 0.1 0.1 0.11 0.00
P2 50 6 0.1 0.1 0.11 0.00
P3 50 6 0.1 0.1 0.11 0.00
P4 170 18 0.1 0.1 0.12 0.01
P5 110 12 0.1 0.1 0.11 0.00
P6 110 12 0.1 0.1 0.11 0.00
P7 50 6 0.1 0.1 0.11 0.00
P8 110 12 0.1 0.2 0.12 0.03
P9 50 6 0.1 0.1 0.11 0.00
P10 230 24 0.1 0.1 0.11 0.00
P11 50 6 0.1 0.1 0.11 0.00
P12 110 12 0.1 0.1 0.12 0.01
P13 110 12 0.1 0.1 0.11 0.00
P14 230 24 0.1 0.1 0.11 0.00
P15 170 18 0.1 0.1 0.11 0.00
P16 50 6 0.1 0.1 0.11 0.00
P17 50 6 0.1 0.1 0.11 0.00
P18 110 12 0.1 0.1 0.11 0.00
P19 170 18 0.1 0.1 0.11 0.00
P20 110 12 0.1 0.1 0.12 0.01
C¼ clinician, P¼ pregnant woman, MF¼magnetic field, SD¼
standard deviation.
The number of measurements was counted on the basis of the
TABLE 2. Exposure Levels of Clinicians and Pregnant Women
to Extremely Low-Frequency Magnetic Fields During Prenatal
Ultrasound Examinations in the Examination Room Using a
Philips iU22 Ultrasound Device
MF Exposure (mG)
Case
Duration of
Measurement
(seconds)
Number of
Measurements

Min Max Mean SD
C1 230 24 0.2 0.5 0.27 0.09
C2 50 6 0.2 0.2 0.20 0.03
C3 170 18 0.1 1.8 0.23 0.38
C4 110 12 0.1 0.3 0.21 0.05
C5 110 12 0.1 0.5 0.21 0.13
C6 230 24 0.1 0.2 0.20 0.03
C7 110 12 0.1 0.3 0.22 0.05
C8 230 24 0.1 0.3 0.24 0.06
C9 350 36 0.1 0.4 0.22 0.07
C10 290 30 0.1 0.4 0.27 0.05
C11 170 18 0.2 0.4 0.30 0.07
C12 350 36 0.1 0.3 0.26 0.05
C13 350 36 0.1 0.4 0.23 0.08
C14 470 48 0.1 0.3 0.22 0.07
C15 110 12 0.2 0.2 0.20 0.03
C16 50 6 0.1 0.3 0.21 0.09
C17 290 30 0.1 0.5 0.21 0.08
C18 350 36 0.1 0.3 0.28 0.05
C19 230 24 0.1 0.4 0.29 0.07
C20 290 30 0.1 0.5 0.25 0.09
P1 50 6 0.1 0.3 0.22 0.07
P2 890 90 0.1 0.3 0.24 0.05
P3 1190 120 0.1 0.3 0.23 0.05
P4 1190 120 0.1 0.3 0.22 0.05
P5 50 6 0.2 0.3 0.24 0.02
P6 110 12 0.1 0.3 0.25 0.07
P7 410 42 0.1 0.3 0.23 0.03
P8 350 36 0.1 0.2 0.22 0.03
P9 110 12 0.2 0.2 0.22 0.01
P10 290 30 0.1 0.2 0.22 0.02
P11 470 48 0.2 0.2 0.22 0.01
P12 530 54 0.1 0.3 0.22 0.03
P13 230 24 0.1 0.3 0.24 0.05
P14 350 36 0.1 0.3 0.23 0.05
P15 290 30 0.1 0.3 0.23 0.04
P16 290 30 0.2 0.3 0.26 0.05
P17 230 24 0.2 0.4 0.27 0.05
P18 350 36 0.2 0.3 0.28 0.05
P19 350 36 0.1 0.4 0.25 0.06
P20 470 48 0.2 0.3 0.24 0.04
C¼ clinician, P¼ pregnant woman, MF¼magnetic field, SD¼
standard deviation.
Medicine  Volume 94, Number 29, July 2015 Magnetic Fields During Prenatal Ultrasound Examinationsexposure levels during prenatal ultrasound examination and
patient consultation were lower than the mean MF exposure
level of 1.1mG encountered in homes in North America.21
repeated measurements every 10 seconds within the designated time.Despite the potential harmful effects of ELF-MFs in
humans, few studies have investigated ELF-MFs in hospitals.
We have reported on the extent to which anesthesiologists are
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.exposed to ELF-MFs during surgery by spot measurement and
repeated measurement, finding that mean ELF-MF exposures
were 5.8 5.2mG.22,23 Riminesi et al24 measured ELF-MFs in
The number of measurements was counted on the basis of the
repeated measurements every 10 seconds within the designated time.neonatal intensive care units and reported high ELF-MF levels
exceeding 2mG. However, recent study of measuring surgeons’
levels of exposure to ELF-MFs during laparoscopic and robotic
www.md-journal.com | 3
ment causing early pregnancy loss.16 Measuring the ELF-MFs
at the maternal abdomen could be informative regarding the
influence of ELF-MFs on the fetus through the maternal body.
TABLE 3. Exposure Levels of Clinicians and Pregnant Women
to Extremely Low-Frequency Magnetic Fields During Prenatal
Ultrasound Examinations in the Examination Room Using an
Accuvix V20 Prestige Ultrasound Device
MF Exposure (mG)
Case
Duration of
Measurement
(seconds)
Number of
Measurements

Min Max Mean SD
C1 50 6 0.1 0.2 0.16 0.06
C2 230 24 0.1 0.1 0.12 0.02
C3 350 36 0.1 0.1 0.11 0.03
C4 50 6 0.1 0.4 0.13 0.15
C5 110 12 0.1 0.4 0.12 0.10
C6 110 12 0.1 0.1 0.11 0.03
C7 110 12 0.1 0.1 0.13 0.01
C8 230 24 0.1 0.3 0.14 0.04
C9 290 30 0.1 0.2 0.12 0.02
C10 110 12 0.1 0.1 0.11 0.05
C11 230 24 0.1 0.2 0.13 0.02
C12 290 30 0.1 0.2 0.12 0.03
C13 350 36 0.1 0.2 0.11 0.04
C14 170 18 0.1 0.3 0.16 0.05
C15 230 24 0.1 0.1 0.12 0.05
C16 290 30 0.1 0.1 0.11 0.05
C17 350 36 0.1 0.1 0.15 0.01
C18 110 12 0.1 0.4 0.14 0.02
C19 170 18 0.1 0.2 0.11 0.08
C20 350 36 0.1 0.1 0.12 0.03
P1 290 30 0.1 0.1 0.12 0.01
P2 50 6 0.1 0.1 0.12 0.01
P3 590 60 0.1 0.2 0.13 0.02
P4 350 36 0.1 0.2 0.14 0.02
P5 110 12 0.1 0.2 0.14 0.05
P6 170 18 0.1 0.2 0.13 0.02
P7 170 18 0.1 0.2 0.12 0.03
P8 230 24 0.1 0.2 0.13 0.04
P9 830 84 0.1 0.2 0.12 0.03
P10 590 60 0.1 0.2 0.12 0.02
P11 170 18 0.1 0.2 0.14 0.04
P12 50 6 0.1 0.2 0.12 0.06
P13 290 30 0.1 0.2 0.13 0.02
P14 110 12 0.1 0.1 0.12 0.04
P15 50 6 0.1 0.1 0.12 0.02
P16 110 12 0.1 0.2 0.13 0.03
P17 230 24 0.1 0.2 0.13 0.03
P18 110 12 0.1 0.2 0.12 0.03
P19 290 30 0.1 0.2 0.14 0.03
P20 350 36 0.1 0.2 0.13 0.04
C¼ clinician, P¼ pregnant woman, MF¼magnetic field, SD¼
standard deviation.
TABLE 4. Comparisons of the Mean Extremely Low-Fre-
quency Magnetic Field Exposures of Clinicians and Pregnant
Women During Patient Consultation and Prenatal Ultrasound
Examination
MF Exposure (mG)
Cases
Patient
Consultation
Prenatal Ultrasound
Examinationy P
Clinicians 0.10 0.01
(n¼ 20)
0.18 0.06
(n¼ 40)
<0.001
Pregnant
women
0.11 0.01
(n¼ 20)
0.18 0.06
(n¼ 40)
<0.001
P

0.017 0.510
MF¼magnetic field. Values are given as mean standard deviation.
P values were obtained by the Mann–Whitney U test.
yMF exposures in clinicians and pregnant women with the Philips
TABLE 5. Comparisons of the Mean Extremely Low-Fre-
quency Magnetic Field Exposures of Clinicians and Pregnant
Women During Patient Consultation and Prenatal Ultrasound
Examination Using Philips iU22 and Accuvix V20 Prestige
Devices
MF Exposure (mG)
Cases
Patient
Consult
Philips
iU22 P

Clinicians 0.10 0.01
(n¼ 20)
0.24 0.03
(n¼ 20)
<0.001
Pregnant
women
0.11 0.01
(n¼ 20)
0.24 0.02
(n¼ 20)
<0.001
Patient
Consult
Accuvix V20
Prestige P

Clinicians 0.10 0.01
(n¼ 20)
0.13 0.02
(n¼ 20)
<0.001
Pregnant 0.11 0.01 0.13 0.01 <0.001
Park et al Medicine  Volume 94, Number 29, July 2015surgeries showed mean exposure levels of 0.06 0.01 and
0.03 0.00mT, respectively, with significant differences.25
Although ELF-MFs during laparoscopic and robotic surgeries
The number of measurements was counted on the basis of the
repeated measurements every 10 seconds within the designated time.were lower than those during prenatal ultrasound examination
and patient consultation, ELF-MFs during prenatal ultrasound
examination in the examination room and during patient
4 | www.md-journal.comconsultation in the consulting room were below 2mG, which
is lower than those reported in most of other studies of ELF-MFs
in hospitals.
Wemeasured clinicians’ exposure levels of ELF-MFs at the
heart since many studies have reported the potential harmful
influences of ELF-MFs on the heart.9,26 Moreover, locating the
measuring devices over the heart had the least interference over
clinicians’ activity. By contrast, we measured the ELF-MF
exposure of pregnant women near the maternal abdomen, since
our primary interest was the intensity of ELF-MFs near the fetus.
ELF-MFs have been reported to influence embryonic develop-
iU22 and Accuvix V20 Prestige systems were both significantly higher
than MF exposure during patient consultation (P< 0.001 by Mann–
Whitney U test) (Table 5).women (n¼ 20) (n¼ 20)
MF¼magnetic field. Values are given as mean standard deviation.
P values were obtained by the Mann–Whitney U test.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 6. Comparisons of the Mean Extremely Low-Fre-
quency Magnetic Field Exposures of Clinicians and Pregnant
WomenDuring Prenatal Ultrasound Examination Using Philips
iU22 and Accuvix V20 Prestige Ultrasound Devices
MF Exposure (mG)
Cases Philips iU22
Accuvix V20
Prestige P

Clinicians 0.24 0.03
(n¼ 20)
0.13 0.02
(n¼ 20)
<0.001
Pregnant
women
0.24 0.02
(n¼ 20)
0.13 0.01
(n¼ 20)
<0.001
P

0.435 0.267
MF¼magnetic field. Values are given as mean standard deviation.
Medicine  Volume 94, Number 29, July 2015The ELF-MFs from the Philips iU22 ultrasound device
were significantly higher than those from the Accuvix V20
Prestige device, but the ELF-MF levels of both devices were
below 2mG. First, the monitor of the Philips iU22 is bigger than
that of the Accuvix V20 Prestige device and since more powers
and currents are consumed when the monitor is bigger,27 the
ELF-MF levels would be significantly higher from the Philips
iU22 ultrasound device. Second, since the distance from the
power line to the clinicians and pregnant women was closer in
the case of the Philips iU22 than in the case of Accuvix V20
Prestige device and ELF-MFs decrease quickly as the inverse
square of the distance,28 this would cause the difference in ELF-
MF levels between 2 ultrasound devices. Other than these,
difference might be caused by the 2 systems adopting different
monitors, electric circuits, and power systems. However, since
there is no specific information regarding the components of 2
systems, we could not be certain. Although we do not know the
precise reasons underlying the difference in ELF-MF levels
between the Philips iU22 and Accuvix V20 Prestige devices,
manufacturers should consider not only the performance of
ultrasound itself but also the safety of ELF-MF exposure levels.
It is still unclear what level of ELF-MF is harmful to
humans, especially over the stages of embryonic development.
Several studies have investigated the harmful effects of ELF-
MFs in animal and human cells,29 but more research is needed
to understand the exact pathogenesis underlying the effects of
ELF-MFs in humans. Until the precise level of ELF-MFs that is
harmful to humans is determined, the ELF-MFs from electronic
devices should not be overlooked. These devices originally
intended to aid in the diagnosis and treatment of disease should
not cause harmful effects themselves.
Our study has several limitations. First, although we tried
to maintain the same settings in every consultation, there may
have been slight differences across cases. However, these slight
differences are unlikely to significantly affect the observed
ELF-MF exposure levels. Second, the ELF-MF exposure levels
during prenatal ultrasound monitoring significantly differed
according to the ultrasound device used. However, since our
institution has only 2 different ultrasound devices, the Philips
iU22 and Accuvix V20 Prestige, we could only compare ELF-

P values were obtained by the Mann–Whitney U test.MFs from these 2 devices. Future studies comparing ELF-MF
levels from other ultrasound devices and exploring the factors
underlying this difference would be valuable.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.In conclusion, the mean ELF-MF exposures of clinicians
and pregnant women during prenatal ultrasound examinations
were significantly higher than the mean ELF-MF exposures of
clinicians and pregnant women during patient consultation.
However, ELF-MF exposure levels in both settings were con-
siderably lower than 2mG, the most stringent level considered
safe in many studies. To our knowledge, this study is the first to
provide basic reference data on the ELF-MF exposure levels of
both clinicians and pregnant women during prenatal ultrasound
monitoring and patient consultation. Moreover, we compared
ELF-MFs from 2 different ultrasound devices and found that
ELF-MF exposure significantly differed between 2 different
ultrasound devices. Although our results indicated ELF-MF
levels less than 2mG, we should not overlook the effects of
ELF-MFs and remain cautious.
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